Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04892732 · ClinicalTrials.gov registry record
Replication of the D58 Asthma Trial in Healthcare Claims Data
A clinical trial of Asthma, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 66,581
- Enrollment target
- 1
- Study location
NCT04892732 is a study of Asthma that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 66,581 participants, above the 1,385-participant average among 374 other Asthma trials with a reported enrollment target (4707% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04892732, a study of Asthma, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 66,581 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Conditions Studied
Interventions
- DRUG Budesonide
- DRUG Budesonide-Formoterol
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66,581 participants |
| Start Date | 2020-10-29 |
| Est. Completion | 2021-06-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04892732
The ClinicalTrials.gov registry entry for NCT04892732 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66,581 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,385-participant average among 374 other Asthma trials with a reported enrollment target (4707% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Budesonide is the first listed.
NCT04892732 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04892732 about?
NCT04892732 is a clinical study titled "Replication of the D58 Asthma Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04892732?
This trial is currently completed. The enrollment target is 66,581 participants. The study started on 2020-10-29. Estimated completion is 2021-06-11.
What conditions does trial NCT04892732 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT04892732?
The interventions under investigation include: Budesonide (DRUG), Budesonide-Formoterol (DRUG).
Who is sponsoring clinical trial NCT04892732?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04892732 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.